Clinical trial
Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery
NCT05300555 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 5, 2021
- Completion date
- November 1, 2022
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation new onset